Completed PHASE4 INTERVENTIONAL 4-arm NCT02426736

Effect of Dexamethasone Dose and Route on Duration of Interscalene Block After Outpatient Shoulder Surgery

Effect of Dexamethasone Dose and Route on Duration of Interscalene Brachial Plexus Block for Outpatient Arthroscopic Shoulder Surgery - A Randomized Controlled Trial

Sponsor: University of Manitoba

Conditions Disorder of Shoulder Pain, Postoperative

Interventions Bupivacaine Dexamethasone Interscalene brachial plexus block

Updated 6 times since 2017 Last updated: Oct 24, 2017 Started: Jun 25, 2015 Primary completion: Jul 12, 2016 Completion: Jan 12, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Disorder of Shoulder and Pain, Postoperative and is currently completed. University of Manitoba leads this study, which shows 6 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Nov 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Nov 2017 [monthly]

Active Not Recruiting PHASE4

First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Manitoba

Data source: University of Manitoba

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Winnipeg, Canada